ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Merck Sharp & Dohme Finance Europe Limited

Merck Sharp & Dohme Finance Europe Limited is an active company incorporated on 21 October 1993 with the registered office located in London, City of London. Merck Sharp & Dohme Finance Europe Limited was registered 32 years ago.
Status
Active
Active since incorporation
Company No
02866198
Private limited company
Age
32 years
Incorporated 21 October 1993
Size
Large
Turnover is over £54M
Balance sheet is over £27M
Confirmation
Submitted
Dated 21 October 2025 (3 days ago)
Next confirmation dated 21 October 2026
Due by 4 November 2026 (1 year remaining)
Last change occurred 4 years ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Address
120 Moorgate
London
EC2M 6UR
United Kingdom
Same address for the past 4 years
Telephone
01992467272
Email
Available in Endole App
Website
Unreported
People
Officers
3
Shareholders
3
Controllers (PSC)
1
Director • British • Lives in UK • Born in Nov 1974
Director • Turkish • Lives in UK • Born in Oct 1972
Director • British • Lives in UK • Born in Dec 1976
Merck & Co., INC
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Merck Sharp & Dohme (UK) Limited
Ebru Can Temucin and Benjamin Paul Lucas are mutual people.
Active
MSD R&D Innovation Centre Limited
Ebru Can Temucin and Benjamin Paul Lucas are mutual people.
Active
Schering-Plough Holdings Limited
Ebru Can Temucin and Benjamin Paul Lucas are mutual people.
Active
MSD Limited
Ebru Can Temucin and Benjamin Paul Lucas are mutual people.
Active
Eyebiotech Limited
Benjamin Paul Lucas is a mutual person.
Active
Iomet Pharma Ltd
Ebru Can Temucin is a mutual person.
Active
Imago Biosciences Ltd
Ebru Can Temucin and Benjamin Paul Lucas are mutual people.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£921.24M
Decreased by £1.08B (-54%)
Turnover
£337.24M
Decreased by £126.49M (-27%)
Employees
Unreported
Decreased by 3 (-100%)
Total Assets
£4.09B
Decreased by £2.19B (-35%)
Total Liabilities
-£3.78B
Decreased by £2.19B (-37%)
Net Assets
£318.91M
Decreased by £5.46M (-2%)
Debt Ratio (%)
92%
Decreased by 2.63% (-3%)
Latest Activity
Confirmation Submitted
3 Days Ago on 21 Oct 2025
Full Accounts Submitted
29 Days Ago on 25 Sep 2025
Confirmation Submitted
1 Year Ago on 24 Oct 2024
Full Accounts Submitted
1 Year Ago on 1 Oct 2024
Confirmation Submitted
2 Years Ago on 23 Oct 2023
Full Accounts Submitted
2 Years 2 Months Ago on 24 Aug 2023
Richard Eric Hall Appointed
2 Years 2 Months Ago on 23 Aug 2023
Michael Hobbs Resigned
2 Years 2 Months Ago on 23 Aug 2023
Confirmation Submitted
2 Years 11 Months Ago on 2 Nov 2022
Full Accounts Submitted
3 Years Ago on 1 Oct 2022
Get Credit Report
Discover Merck Sharp & Dohme Finance Europe Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 21 October 2025 with no updates
Submitted on 21 Oct 2025
Full accounts made up to 31 December 2024
Submitted on 25 Sep 2025
Confirmation statement made on 21 October 2024 with no updates
Submitted on 24 Oct 2024
Full accounts made up to 31 December 2023
Submitted on 1 Oct 2024
Confirmation statement made on 21 October 2023 with no updates
Submitted on 23 Oct 2023
Appointment of Richard Eric Hall as a director on 23 August 2023
Submitted on 8 Sep 2023
Full accounts made up to 31 December 2022
Submitted on 24 Aug 2023
Termination of appointment of Michael Hobbs as a director on 23 August 2023
Submitted on 23 Aug 2023
Confirmation statement made on 21 October 2022 with no updates
Submitted on 2 Nov 2022
Full accounts made up to 31 December 2021
Submitted on 1 Oct 2022
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year